HDAC6 as a Prognostic Factor and Druggable Target in HER2-Positive Breast Cancer
HDAC6 作为 HER2 阳性乳腺癌的预后因素和可用药靶点
期刊:Cancers
影响因子:
doi:10.3390/cancers16223752
Michela Cortesi, Sara Bravaccini, Sara Ravaioli, Elisabetta Petracci, Davide Angeli, Maria Maddalena Tumedei, William Balzi, Francesca Pirini, Michele Zanoni, Paola Possanzini, Andrea Rocca, Michela Palleschi, Paola Ulivi, Giovanni Martinelli, Roberta Maltoni